Royalty Pharma plc Analysis
| Analyst Ratings |
|
Average Target Price
|
53.71
|
|
Average Rating
|
4.36
|
|
# Strong Buys
|
5
|
|
# Buys
|
5
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.72
|
0.72
|
0.00
|
0.00%
|
|
2022-06-30
|
0.78
|
0.79
|
0.01
|
1.28%
|
|
2022-03-31
|
0.73
|
0.60
|
-0.13
|
-17.81%
|
|
2021-12-31
|
0.78
|
0.80
|
0.02
|
2.56%
|
|
2021-09-30
|
0.69
|
0.73
|
0.04
|
5.80%
|
|
2021-06-30
|
0.70
|
0.71
|
0.01
|
1.43%
|
|
2021-03-31
|
0.65
|
0.67
|
0.02
|
3.08%
|
|
2020-12-31
|
0.69
|
0.70
|
0.01
|
1.45%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
2.11
|
|
2021-12-31
|
2.91
|
|
2020-12-31
|
5.67
|
|
2016-12-31
|
-0.16
|